Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Breast Neoplasms × Razoxane × Clear all

Sponsor

Conditions

Sarcoma 2 Sarcoma, Synovial 1 Rhabdoid Tumor 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 PRETEXT I Hepatoblastoma 1 Osteosarcoma 1 Neurofibrosarcoma 1 Neuroblastoma 1 Lymphoma, Large-Cell, Anaplastic 1 Localized Extraskeletal Ewing Sarcoma 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Ganglioneuroblastoma 1 Fibrosarcoma 1 Dermatofibrosarcoma 1 Central Nervous System Neoplasms 1

Interventions

Trastuzumab 241 Paclitaxel 192 Cyclophosphamide 158 Docetaxel 134 Letrozole 113 Capecitabine 113 Fulvestrant 106 Doxorubicin 103 Bevacizumab 87 Carboplatin 81 exemestane 80 Anastrozole 79 Lapatinib 70 Tamoxifen 69 Albumin-Bound Paclitaxel 57 palbociclib 54 pertuzumab 52 Taxes 51 Gemcitabine 50 Radiotherapy 44 eribulin 43 Everolimus 41 pembrolizumab 40 Ado-Trastuzumab Emtansine 40 Vinorelbine 38 130-nm albumin-bound paclitaxel 35 ixabepilone 32 Epirubicin 28 pegfilgrastim 25 liposomal doxorubicin 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡